Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Obesity and COVID-19: a call for action from people living with obesity.
Le Brocq S, Clare K, Bryant M, Roberts K, Tahrani AA; writing group form Obesity UK; Obesity Empowerment Network; UK Association for the Study of Obesity. Le Brocq S, et al. Among authors: tahrani aa. Lancet Diabetes Endocrinol. 2020 Aug;8(8):652-654. doi: 10.1016/S2213-8587(20)30236-9. Epub 2020 Jul 9. Lancet Diabetes Endocrinol. 2020. PMID: 32653052 Free PMC article. No abstract available.
Global variations in preoperative practices concerning patients seeking primary bariatric and metabolic surgery (PACT Study): A survey of 634 bariatric healthcare professionals.
Yang W, Abbott S, Borg CM, Chesworth P, Graham Y, Logue J, Ogden J, O'Kane M, Ratcliffe D, Sherf-Dagan S, Singhal R, Snowdon-Carr V, Tahrani A, Mahawar K. Yang W, et al. Among authors: tahrani a. Int J Obes (Lond). 2022 Jul;46(7):1341-1350. doi: 10.1038/s41366-022-01119-x. Epub 2022 Apr 11. Int J Obes (Lond). 2022. PMID: 35399108
SGLT inhibitors in management of diabetes.
Tahrani AA, Barnett AH, Bailey CJ. Tahrani AA, et al. Lancet Diabetes Endocrinol. 2013 Oct;1(2):140-51. doi: 10.1016/S2213-8587(13)70050-0. Epub 2013 Aug 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622320 Review.
Future glucose-lowering drugs for type 2 diabetes.
Bailey CJ, Tahrani AA, Barnett AH. Bailey CJ, et al. Among authors: tahrani aa. Lancet Diabetes Endocrinol. 2016 Apr;4(4):350-9. doi: 10.1016/S2213-8587(15)00462-3. Epub 2016 Jan 23. Lancet Diabetes Endocrinol. 2016. PMID: 26809680 Review.
Once-weekly GLP-1R agonists: moving the goal posts.
Tahrani AA, Bellary S, Barnett AH. Tahrani AA, et al. Lancet Diabetes Endocrinol. 2018 Apr;6(4):260-261. doi: 10.1016/S2213-8587(18)30049-4. Epub 2018 Feb 1. Lancet Diabetes Endocrinol. 2018. PMID: 29397375 Free article. No abstract available.
IDegLira: combining efficacy, durability, and convenience?
Bellary S, Tahrani AA, Barnett AH. Bellary S, et al. Among authors: tahrani aa. Lancet Diabetes Endocrinol. 2019 Aug;7(8):584-585. doi: 10.1016/S2213-8587(19)30198-6. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189518 No abstract available.
204 results